- Exchange: New York
- Sector: Health Care
- Industry: Medical Equipment/Devices
- Sub-Industry: Health Care Supplies
Becton Dickinson and Co
+ Add to WatchlistBDX:US
98.7900 USD 1.6100 1.60%As of 20:04:01 ET on 06/19/2013.
Snapshot for Becton Dickinson and Co (BDX)
| Open: | 100.3100 | Day's Range: | 98.7400 - 100.4200 | Volume: | 851,813 |
|---|---|---|---|---|---|
| Previous Close: | 100.4000 | 52wk Range: | 72.4000 - 102.7250 | 1-Yr Rtn: | +35.38% |
Key Statistics for BDX
| Current P/E Ratio (ttm) | 17.2710 |
|---|---|
| Estimated P/E(09/2013) | 17.1898 |
| Relative P/E vs. SPX | 1.0823 |
| Earnings Per Share (USD) (ttm) | 5.7200 |
| Est. EPS (USD) (09/2013) | 5.7470 |
| Est. PEG Ratio | 2.1469 |
| Market Cap (M USD) | 19,190.07 |
| Shares Outstanding (M) | 194.25 |
| 30 Day Average Volume | 879,916 |
| Price/Book (mrq) | 4.1820 |
| Price/Sale (ttm) | 2.4923 |
| Dividend Indicated Gross Yield | 2.00% |
| Cash Dividend (USD) | 0.4950 |
| Last Dividend | 06/05/2013 |
| 5 Year Dividend Growth | 11.96% |
| Next Earnings Announcement | 08/02/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BDX
Company Profile & Key Executives for BDX
Becton, Dickinson and Company is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
| Vincent A ForlenzaChairman/President/CEO | Alexandre ConroyPres:Europe & Americas |
| James LimPres:Greater Asia | William A KozyExec VP/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BDX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page